Allogeneic mesenchymal stem cells therapy for the treatment of HBV related acute-on-chronic liver failure.

分享到

Link by DOI

作者单位: Department of Gastroenterology, Liaocheng People's Hospital, Liaocheng Clinical School of Taishan Medical University, Liaocheng, 252000, Shandong Province, China. Department of Central Laboratory, Institute for stem cell clinical research, Liaocheng People's Hospital, Liaocheng Clinical School of Taishan Medical University, Liaocheng, 252000, Shandong Province, China.

摘要: We read with great interest regarding recent publication by Lin and colleague. Recently, mesenchymal stem cells have been considered as a novel and effective therapy for liver diseases such as liver fibrosis, cirrhosis and liver failure. In this paper, authors demonstrated significant survival benefit of allogeneic bone marrow MSC for hepatitis B virus -related acute-on-chronic liver failure in comparison with standard medical treatment. This article is protected by copyright. All rights rese...更多; We read with great interest regarding recent publication by Lin and colleague. Recently, mesenchymal stem cells have been considered as a novel and effective therapy for liver diseases such as liver fibrosis, cirrhosis and liver failure. In this paper, authors demonstrated significant survival benefit of allogeneic bone marrow MSC for hepatitis B virus -related acute-on-chronic liver failure in comparison with standard medical treatment. This article is protected by copyright. All rights reserved.收起

列表公用js 卡片页统计

看了本文的还看了